Application 050734

Type
NDA
Sponsor
PHARMACIA AND UPJOHN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001IDAMYCIN PFSIDARUBICIN HYDROCHLORIDEINJECTABLE;INJECTION1MG/MLYesYes
002IDARUBICIN HYDROCHLORIDEIDARUBICIN HYDROCHLORIDESOLUTION;INTRAVENOUS10MG/10ML (1MG/ML)YesYes
003IDARUBICIN HYDROCHLORIDEIDARUBICIN HYDROCHLORIDESOLUTION;INTRAVENOUS20MG/20ML (1MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0013-2576Idamycin PFSidarubicin hydrochloridePharmacia & Upjohn Company LLCNDACurrent
0013-2576Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2576Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent
0013-2576Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2576Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent
0013-2576Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePharmacia & Upjohn Company LLCNDACurrent
0013-2586Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePharmacia & Upjohn Company LLCNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePharmacia and Upjohn Company LLCNDACurrent
0013-2596Idamycin PFSidarubicin hydrochloridePfizer Laboratories Div Pfizer IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84965SUPPL 2026-02-06
84963SUPPL 2026-02-06
76870SUPPL 2023-12-15
76852SUPPL 2023-12-15
70863SUPPL2022-04-29
70839SUPPL2022-04-27
66248SUPPL2021-02-17
66194SUPPL2021-02-11
59575SUPPL2019-08-05
59573SUPPL2019-08-05
39217SUPPL2015-01-09
8146SUPPL2014-12-05
8145SUPPL2003-05-30
18144SUPPL2003-05-06